TRF (TRF)

Cyclical

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹230.71
Market Cap₹253.88 Cr
P/E Ratio16.89
ROCE21.81%
ROE-5.33%
Dividend Yield0%
Profit Growth-65.79%
Debt/Equity1.54
Sales Growth20.85%
Promoter Holding34.12%
52-Week Range₹215 — ₹405
SectorIndustrial Manufacturing
Book Value₹58.72

Strengths

Concerns

AI Analysis

At first glance, TRF's 23.66% ROE and 21.81% ROCE catch my eye. But I have learned to look behind the ratios. A 14.67% fall in sales and a 48.36% collapse in profit are not signs of a durable franchise. The Piotroski F-Score of 3 out of 9 reinforces my caution: this is a company under financial stress, not one with improving fundamentals. The balance sheet shows debt/equity of 1.44, so that ROE is partly borrowed, not pure earning power. In Graham's language, a high return on equity is only meaningful if it can be maintained without excessive leverage and through a full cycle. The latest quarter offers a small spark: sales of ₹20 Cr and net profit of ₹6 Cr implies a healthy profit margin. But one quarter cannot undo a year of declining top line, and with no dividend, I as a minority shareholder receive no cash while waiting. At ₹265.12, the stock trades at 16.89 times earnings and 4.51 times book value. Book value is only ₹58.72. That is a rich price for a business whose earnings are falling. The 52-week range tells me the market has already repriced it from ₹405 to ₹265, but a falling knife still hurts. I also note promoter holding is 34.12%, which is not very strong alignment; in Indian industrials, I prefer owners to have more skin in the game. The FairStock score is unavailable due to insufficient data. For a value investor, inadequate information is itself a red flag. TRF may be a cyclical business near a low, but I cannot say it is a clear bargain. I want a margin of safety. With high debt, weak F-Score, zero dividend, and declining growth, TRF fails that test. I would wait for either a stronger balance sheet, consistent margin improvement, or a significantly lower price before acting.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer